TrialScientific reports2025

An open-label phase I comparator-controlled clinical trial to assess tolerability and pharmacokinetics of IHL-675 A a fixed dose combination of cannabidiol plus hydroxychloroquine in healthy volunteers.

George Williams Mbogo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.